Modeling multisystem biological risk in young adults: The coronary artery risk development in young adults study

American Journal of Human Biology

Volumn 22, Issue 4, 2010, Pages 463-472

  Seeman, Teresa ^a   Gruenewald, Tara ^a   Karlamangla, Arun ^a   Sidney, Steve ^b   Liu, Kiang ^c   Mcewen, Bruce ^d   Schwartz, Joseph ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DIVISION OF RESEARCH   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d ROCKEFELLER UNIVERSITY   (United States)

^e STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; C REACTIVE PROTEIN; FIBRINOGEN; HYDROCORTISONE; INSULIN; INTERLEUKIN 6; LIPID; NORADRENALIN; GLUCOSE BLOOD LEVEL;

ADULT; ALLOSTASIS; ARTICLE; BLOOD; BLOOD PRESSURE; CHEMISTRY; CLINICAL TRIAL; CORONARY ARTERY DISEASE; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HEART RATE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; SALIVA; UNITED STATES; URINE; WAIST CIRCUMFERENCE; ANALYSIS; CORONARY DISEASE; HEALTH STATUS INDICATOR;

ADULT; ALLOSTASIS; BLOOD GLUCOSE; BLOOD PRESSURE; C-REACTIVE PROTEIN; CALIFORNIA; CORONARY DISEASE; EPINEPHRINE; FEMALE; FIBRINOGEN; HEALTH STATUS INDICATORS; HEART RATE; HUMANS; HYDROCORTISONE; ILLINOIS; INSULIN; INTERLEUKIN-6; LIPIDS; MALE; MIDDLE AGED; NOREPINEPHRINE; PROSPECTIVE STUDIES; SALIVA; WAIST CIRCUMFERENCE;

EID: 77953548872     PISSN: 10420533     EISSN: 15206300     Source Type: Journal    
DOI: 10.1002/ajhb.21018     Document Type: Article

References (46)

1. Adam EK, Hawkley LC, Kudielka BM, Cacioppo J.T. 2006. Day-to-day dynamics of experience-cortisol associations in a population-based sample of older adults. Proc Natl Acad Sci USA 103:17058-17063
2. Baranowski RL, Westenfelder C. 1986 A micro method to measure paraamino hippurate and creatinine in plasma and urine. Kidney Int 30: 113-115.
3. Barrett-Connor E, Khaw KT, Yen S.S. 1986. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 315:1519-1524.
4. Bentler P.M. 1990. Comparative fit indexes in structural models. Psychol Bull 107:238-246.
5. Cutter GR, Burke GL, Dyer AR, Friedman GD, Hilner JE, Hughes GH, Hulley SB, Jacobs DR Jr, Liu K, Manolio TA and others. 1991. Cardiovascular risk factors in young adults. The CARDIA baseline monograph. Control Clin Trials 12(1 Suppl):1S-77.S.
6. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P. 2001. Validation of the Framingham coronary heart disease prediction scores: Results of a multiple ethnic groups investigation. JAMA 286:180-187.
7. DeBoer RW, Karemaker JM, Strackee J. 1984. Comparing spectra of a series of point events particularly for heart rate variability data. IEEE Trans Biomed Eng 31:384-387.
8. Despres JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. 1990. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 10:497-511.
9. Dressendorfer RA, Kirschbaum C, Rohde W, Stahl F, Strasburger C.J. 1992. Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement. J Steroid Biochem Mol Biol 43:683-692.
10. Eaton C.B. 2005. Traditional and emerging risk factors for cardiovascular disease. Prim Care 32:963-976, vii.
11. Folsom AR, Jacobs DR Jr, Wagenknecht LE, Winkhart SP, Yunis C, Hilner JE, Savage PJ, Smith DE, Flack J.M. 1996. Increase in fasting insulin and glucose over seven years with increasing weight and inactivity of young adults. The CARDIA Study. Coronary Artery Risk Development in Young Adults. Am J Epidemiol 144:235-246.
12. Forouhi NG, Sattar N. 2006. CVD risk factors and ethnicity-a homogeneous relationship? Atheroscler Suppl 7:11-19.
13. Fried LP, Kronmal RA, Newman AB, Bild DE, Mittelmark MB, Polak JF, Robbins JA, Gardin J.M. 1998. Risk factors for 5-year mortality in older adults: The Cardiovascular Health Study. JAMA 279:585-592.
14. Friedewald WT, Levy RI, Fredrickson D.S. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502.
15. Geronimus AT, Hicken M, Keene D, Bound J. 2006. "Weathering" and age patterns of allostatic load scores among blacks and whites in the United States. Am J Public Health 96:826-833.
16. Goldman N, Weinstein M, Cornman J, Singer B, Seeman T, Chang M.C. 2004. Sex differentials in biological risk factors for chronic disease: Estimates from population-based surveys. J Womens Health (Larchmt). 13: 393-403.
17. Haffner SM, Bowsher RR, Mykkanen L, Hazuda HP, Mitchell BD, Valdez RA, Gingerich R, Monterossa A, Stern M.P. 1994. Proinsulin and specific insulin concentration in high- and low-risk populations for NIDD.M. Diabetes 43:1490-1493.
18. Hu L, Bentler P.M. 1999. Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Struct Equation Model 6:1-55.
19. Jamshidian M, Bentler P.M. 1999. ML estimation of mean and covariance structures with missing data using complete data routines. J Educ Behav Stat 24:21-24.
20. Karlamangla AS, Singer BH, McEwen BS, Rowe JW, Seeman T.E. 2002. Allostatic load as a predictor of functional decline. MacArthur studies of successful aging. J Clin Epidemiol 55:696-710.
21. Karlamangla AS, Singer BH, Williams DR, Schwartz JE, Matthews KA, Kiefe CI, Seeman T.E. 2005. Impact of socioeconomic status on longitudinal accumulation of cardiovascular risk in young adults: The CARDIA Study (USA). Soc Sci Med 60:999-1015.
22. Kline R.B. 1998. Principles and practice of structural equation modeling. New York: Guilford Press.
23. Landsberg L. 1994. Pathophysiology of obesity-related hypertension: Role of insulin and the sympathetic nervous system. J Cardiovasc Pharmacol (23 Suppl) 1:S1-S8.
24. Liao Y, McGee DL, Cooper R.S. 1999. Prediction of coronary heart disease mortality in blacks and whites: Pooled data from two national cohorts. Am J Cardiol 84:31-36.
25. Lynch JW, Kaplan GA, Cohen RD, Tuomilehto J, Salonen J.T. 1996. Do cardiovascular risk factors explain the relation between socioeconomic status, risk of all-cause mortality, cardiovascular mortality, and acute myocardial infarction? Am J Epidemiol 144:934-942.
26. Macdonald IA, Lake D.M. 1985. An improved technique for extracting catecholamines from body fluids. J Neurosci Methods 13(3-4):239-248.
27. McEwen B.S. 1998. Protective and damaging effects of stress mediators. N Engl J Med 338:171-179.
28. McEwen B.S. 2003. Interacting mediators of allostasis and allostatic load: Towards an understanding of resilience in aging. Metabolism 52(10 Suppl 2):10-16.
29. McEwen BS, Stellar E. 1993. Stress and the individual. Mechanisms leading to disease. Arch Intern Med 153:2093-2101.
30. Munck A, Guyre P.M. 1991. Glucocorticoids and immune function. In: Ader R, Felten DL, Cohen N, editors. Psychoneuroimmunology, 2nd ed. New York: Academic Press. p 447-473.
31. Paultre F, Mosca L. 2006 The relation of blood pressure to coronary heart mortality in different age groups varies by ethnicity. Am J Hypertens 19:179-183.
32. Reuben DB, Talvi SL, Rowe JW, Seeman T.E. 2000. High urinary catecholamine excretion predicts mortality and functional decline in high-functioning, community-dwelling older persons: MacArthur Studies of Successful Aging. J Gerontol A Biol Sci Med Sci 55: M618-M624.
33. Satorra A, Bentler P.M. 2001. A scaled difference chi-square test statistic for moment structure analysis. Psychometrika 66:507-514.
34. Schulkin J. 2004. Allostasis, homeostasis, and the costs of physiological adaptation. Cambridge, UK: Cambridge University Press.
35. Seeman T, Merkin SS, Crimmins E, Koretz B, Charette S, Karlamangla A. 2008. Education, income and ethnic differences in cumulative biological risk profiles in a national sample of US adults: NHANES III (1988- 1994). Soc Sci Med 66:72-87.
36. Seeman TE, Crimmins E, Huang MH, Singer B, Bucur A, Gruenewald T, Berkman LF, Reuben D.B. 2004. Cumulative biological risk and socioeconomic differences in mortality: MacArthur studies of successful aging. Soc Sci Med 58:1985-1997.
37. Seeman TE, McEwen B.S. 1996. Impact of social environment characteristics on neuroendocrine regulation. Psychosom Med 58:459-471.
38. Seeman TE, McEwen BS, Rowe JW, Singer B.H. 2001. Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging. Proc Natl Acad Sci USA 98:4770-4775.
39. Simon A, Mijiti W, Gariepy J, Levenson J. 2006. Current possibilities for detecting high risk of cardiovascular disease. Int J Cardiol 110:146-152.
40. Sloan RP, Huang MH, Sidney S, Liu K, Williams OD, Seeman T. 2005. Socioeconomic status and health: Is parasympathetic nervous system activity an intervening mechanism? Int J Epidemiol 34:309-315.
41. Sterling P, Ever J. 1988. Allostasis: A new paradigm to explain arousal pathology. In: Fisher S, Reason J, editors. Handbook of life stress, cognition and health. New York: Wiley.
42. Taylor SE, Klein LC, Lewis BP, Gruenewald TL, Gurung RA, Updegraff J.A. 2000. Biobehavioral responses to stress in females: Tend-andbefriend, not fight-or-flight. Psychol Rev 107:411-429.
43. Tsuji H, Larson MG, Venditti FJ Jr, Manders ES, Evans JC, Feldman CL, Levy D. 1996. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 94:2850-2855.
44. Vaccaro O, Stamler J, Neaton J.D. 1998. Sixteen-year coronary mortality in black and white men with diabetes screened for the Multiple Risk Factor Intervention Trial (MRFIT). Int J Epidemiol 27:636-641.
45. Warnick G.R. 1986. Enzymatic methods for quantification of lipoprotein lipids. Methods Enzymol 129:101-123.
46. Warnick GR, Benderson J, Albers J.J. 1982. Dextran sulfate-Mg21 precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 28:1379-1388.